Pharmafile Logo

Moving Beyond the 10%: A New Era in Preterm Birth Prevention

July 1, 2026 | #HearFromHer #PretermBirth 

For decades, the rate of spontaneous preterm birth in the United States has hovered stubbornly around 10%. Despite advancements in other areas of medicine, prematurity remains the second leading cause of death for neonates, carrying a heavy toll of lifelong health complications, developmental disabilities, and a staggering $25 billion annual cost to the healthcare system.

- PMLiVE

Listen to the full episode here.

As discussed in the latest Hear From Her podcast, the challenge has always been prediction. “Prior to this, we had very few tools to help predict who is at risk,” explains Dr. Mollie McDonnold, a Maternal-Fetal Medicine specialist. Traditionally, doctors relied on a patient’s history of previous preterm births, but the majority of cases occur in women with no prior history.

The Biomarker Breakthrough

The conversation highlights a shift toward personalized medicine through the use of biomarkers. By analyzing proteins from the placenta via a simple blood draw early in pregnancy, clinicians can now identify high-risk patients with much greater sensitivity than traditional methods.
Listen to the full episode here.

The Power of the “Bundle”

Identification is only half the battle; prevention is the goal. Zhenya Lindgardt, CEO of Sera Prognostics, shares results from the “Prime Study,” which utilized a protocol designed with the Society for Maternal-Fetal Medicine. When high-risk women were treated with a “preventive bundle”—consisting of low-dose aspirin, vaginal progesterone, and weekly nurse check-ins—the results were “spectacular”:  

  • A 20% reduction in severe neonatal morbidity.  
  • A 52% reduction in births before 32 weeks.  
  • One out of five babies avoided the NICU entirely.

Listen to the full episode here.

 A Tailored Future

The future of maternal health lies in moving away from a “one size fits all” approach. By stratifying care, healthcare providers can funnel intensive resources—like cervical length monitoring and specialized nurse support—to those who need it most, while providing peace of mind to those at low risk. As Lindgardt notes, the goal is to ensure every pregnancy receives the specific level of care it requires to thrive.

Listen to the full episode here.

This content was provided by Medscape Education

Company Details

 Latest Content from  Medscape Education 

Medscape at ASH 2025: Landmark Value Through the Medscape AI Debut and Five Educational Symposia

For decades, Medscape has been the brand physicians trust. Now, Medscape is forging a new path into the future at ASH 2025 with the launch of Medscape AI — the...

Women Leaders Rewriting the Protocols of Rare Disease Care

The true measure of a medical leader is the courage to act when existing systems fail the patient. This is the professional and personal ethos of clinical immunologist Dr. Hilary...

The Power of the Pivot: How Nurse Practitioners are Closing Care Gaps for Women

The career path of a Nurse Practitioner is often envisioned as a straight line: clinical practice, specialization, perhaps a supervisory role. But for two pioneering NPs, Laura Demuth and Jackie...

Voices of Change: Women Leading the Menopause Movement

For decades, menopause has been swept under the rug, or into the dark corners of clinicians’ offices, often dismissed as something women just had to “get past” and hardly worth...

Medscape Wins Anthem Award for Rare Disease Education Platform

Platform has reached 2.4 million healthcare professionals worldwide since 2021. Newark, NJ - [November 18, 2025] - Medscape, the leading digital platform for physicians and healthcare professionals (HCPs), has been...

Shifting the Paradigm: A New Era for Parkinson’s Care

In this episode of “Hear From Her:” Hear from two leaders at the forefront of a much-needed change in how Parkinson’s is understood, diagnosed, and treated.

World Orphan Drug Congress 2025 in Amsterdam

Medscape Education will make its debut at the World Orphan Drug Congress (WODC) 2025, taking place in Amsterdam, the Netherlands, October 28-29.

Medscape Education: Pioneering Pathways at ESMO 2025

Medscape Oncology will be pioneering pathways at the 2025 ESMO congress taking place in Berlin, Germany this October.

Game On: Medscape Education Golfs for a Cause

Medscape Education is proud to stand alongside the National Kidney Foundation (NKF) as a sponsor of one of the nation’s most impactful charity events benefiting patients living with kidney disease,...

Innovation in Action at AAFP FMX 2025

This year, Medscape Education is redefining the live learning experience at AAFP FMX 2025. With 8 groundbreaking, accredited symposia, we are proud to be at the heart of the meeting,...